ALDA Receives Delivery of New T36(R) Antiseptic Hand Sanitizer
VANCOUVER, BRITISH COLUMBIA, Dec 10, 2008 (Marketwire via COMTEX News Network) --
ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("the Company" or "ALDA") announces that its T36(R) Antiseptic Hand Sanitizer Gel (DIN 02314320), the first ALDA product that has been approved for human use by Health Canada, has been manufactured and delivered, and is now ready to be shipped to distributors.
Compared to typical alcohol-based hand sanitizers, ALDA's T36(R) Antiseptic Hand Sanitizer is a unique formula with two active ingredients that provide faster action against a broader range of infectious organisms and offer a long-lasting residual effect.
Group 270 Sales & Marketing Inc. ("Group 270"), ALDA's marketing agent, will be introducing T36(R) Antiseptic Hand Sanitizer to major regional and national pharmacy chains across Canada. The Company's current distributors will also be providing this new product to their customers. Other marketing activities are being initiated that are designed to penetrate additional market sectors not currently serviced by the Company.
About ALDA Pharmaceuticals
ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH.
Terrance G. Owen, Ph.D., MBA, President & CEO
ALDA Pharmaceuticals Corp.
SOURCE: ALDA Pharmaceuticals Corp.
ALDA Pharmaceuticals Corp. Peter Chen Distribution & Sales Contact (604) 521- 8300 Ext. 3 (604) 521-8322 (FAX) Email: peter_chen@aldacorp.com ALDA Pharmaceuticals Corp. Scott Young Investor Relations Contact (604) 288-7222 Email: syoung@freeformcom.com Website: www.aldacorp.com
Copyright (C) 2008 Marketwire. All rights reserved.
Rage Against The Machine
